Lyell Immunopharma
LYEL
#8656
Rank
โ‚น11.08 B
Marketcap
โ‚น37.56
Share price
-4.32%
Change (1 day)
-81.37%
Change (1 year)

Revenue for Lyell Immunopharma (LYEL)

Revenue in 2024 (TTM): โ‚น5.12 Million

According to Lyell Immunopharma's latest financial reports the company's current revenue (TTM ) is โ‚น5.21 Million. a decrease over the revenue in the year 2023 that were of โ‚น10.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lyell Immunopharma from 2020 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น5.23 M-51.65%
2023 โ‚น10.82 M-99.85%
2022 โ‚น7.00 B784.02%
2021 โ‚น0.79 B39.75%
2020 โ‚น0.56 B